For all the hope invested in them as treatments for depression, classic psychedelics may end up offering only incremental gains for most patients, based on some of the most recent data in the field. If that thesis proves true, the arc of psilocybin, the most widely studied psychedelic of late, would broadly echo the trajectory…
Is a serotonin deficiency to blame for depression? Probably not, recent study finds.
A comprehensive review published in Molecular Psychiatry found scant evidence for the so-called serotonin hypothesis, suggesting that diminished serotonin pathways’ activity is associated with depression. The authors conclude that the research provides “no consistent evidence of an association between serotonin and depression.” They also note they could not find support for “the hypothesis that depression is caused…

